Your browser doesn't support javascript.
loading
Circulating tumor DNA and bone marrow minimal residual disease negativity confers superior outcome for multiple myeloma patients.
Mithraprabhu, Sridurga; Reynolds, John; Quach, Hang; Horvath, Noemi; Kerridge, Ian; Khong, Tiffany; Durie, Brian Gm; Spencer, Andrew.
Afiliación
  • Mithraprabhu S; Australian Centre for Blood Diseases, Alfred Health - Monash University, Melbourne, Australia; Department of Malignant Haematology and Stem Cell Transplantation, Alfred Hospital, Melbourne. Durga.mithraprabhu@monash.edu.
  • Reynolds J; Australian Centre for Blood Diseases, Alfred Health - Monash University, Melbourne, Australia; Department of Malignant Haematology and Stem Cell Transplantation, Alfred Hospital, Melbourne.
  • Quach H; St.Vincent's Hospital, University of Melbourne.
  • Horvath N; Royal Adelaide Hospital, Adelaide.
  • Kerridge I; Royal North Shore Hospital, Sydney.
  • Khong T; Australian Centre for Blood Diseases, Alfred Health - Monash University, Melbourne, Australia; Department of Malignant Haematology and Stem Cell Transplantation, Alfred Hospital, Melbourne.
  • Durie BG; Cedars-Sinai Comprehensive Cancer Center, Los Angeles, California.
  • Spencer A; Australian Centre for Blood Diseases, Alfred Health - Monash University, Melbourne, Australia; Department of Malignant Haematology and Stem Cell Transplantation, Alfred Hospital, Melbourne. Andrew.spencer@monash.edu.
Haematologica ; 109(3): 974-978, 2024 Mar 01.
Article en En | MEDLINE | ID: mdl-37767561

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: ADN Tumoral Circulante / Mieloma Múltiple Límite: Humans Idioma: En Revista: Haematologica Año: 2024 Tipo del documento: Article

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: ADN Tumoral Circulante / Mieloma Múltiple Límite: Humans Idioma: En Revista: Haematologica Año: 2024 Tipo del documento: Article